Regulatory Requirements:
The FDA’s Unique Device Identification (UDI) rule requires all medical devices sold in the U.S. to carry a standardized identifier for traceability. Key obligations include:
- Unique Device Identifier: Scannable code (GTIN + manufacturing data) on labels and packaging.
- Direct Marking: Permanent UDI on reusable devices (P.EJ., surgical tools, implants).
- Global UDI Database (GUDID): Submit device attributes such as batch number, expiration date, and sterilization method.
Non-compliance can result in import bans, fines of up to $500,000 per violation, and delays in approval of new devices. A 2023 FDA audit found that 32% of manufacturers were unable to meet UDI requirements due to manual data entry errors.
Technology Implementation: Medical-Grade NFC Tags for Sterilization and Security
The NFC-enabled Pasaporte de producto digital (DPP) addresses UDI challenges with powerful, healthcare-optimized features:
1.Sterilization Tolerance
- Ethylene Oxide (EtO) Compatibility: Withstands over 100 sterilization cycles (certified to ISO 11135).
- Autoclave Tolerance: Withstands 135°C steam (validated to ISO 17665).
2.Real-Time Data Accuracy
- Dynamic Updates: Modify expiration dates or recall alerts with over-the-air (OTA) NFC updates.
- GUDID Sync: Auto-populate FDA submissions with SAP S/4HANA or Oracle Health Sciences integrations.
3.Anti-Counterfeiting
- AES-256 Encryption: Protect implant serial numbers from cloning (NTAG NXP 424 DNA).
- Tamper Evidence: If the tag is removed, it becomes visibly blank (Identiv uTrust 3721L).
Caso: Surgical Instrument Manufacturer Reduces FDA Review Time by 50%
Desafío: Manual UDI submission caused 120-day delay in FDA review of new laparoscopic tools.
Solutions:
- Embedded Etiquetas NFC: Usar Etiquetas NFC on instrument handles (ISO 13485 certified).
- Automated GUDID submission: Integrate NFC data with Siemens Teamcenter DPP.
- Real-time alerts: Notify hospital sterilization cycles via Azure IoT Hub.
Resultados:
- 50% faster FDA review (120 days → 60 days).
- No UDI noncompliance found in 2023-2024 audits.
- $1.2 million in recall management cost savings.
(Fuente: FDA UDI Compliance Progress Report, 2024)
Puede que esté interesado también en:
Para más información,por favor Contáctenos.
